29.00EUR+2.11%Mkt Cap: 498.30M EURP/E: 15.27Last update: 2026-05-14
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other health…
Industry Peers
Drug Manufacturers - Specialty & Genericloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)15.27
P/E (Forward)13.48
PEG2.38
P/B1.27
P/S0.99
EV/EBITDA6.51
EV/Revenue0.90
EPS (TTM)1.88
EPS (Forward)2.13
Cash Flow & Leverage
FCF Yield10.65%
FCF Margin10.59%
Operating CF53.24M EUR
CapEx (TTM)23.52M EUR
Net Debt/EBITDA-0.69
Net Debt-47.85M EUR
Technical
SMA 5026.62 (+8.9%)
SMA 20027.14 (+6.8%)
Beta0.23
S&P 52W Chg24.23%
Avg Vol (30d)4.21K
Avg Vol (10d)4.92K
Technical Indicators
RSI (14)65.1
MACD0.4971
MACD Signal0.2386
MACD Hist.+0.2585
BB Upper29.05 EUR
BB Middle26.71 EUR
BB Lower24.37 EUR
BB Width17.54%
ATR (14)0.9425 EUR
Vol Ratio (20d)0.05x
52W Range
20.8571% of range32.25
52W High32.25 EUR
52W Low20.85 EUR
Profitability
Gross Margin72.98%
EBITDA Margin13.80%
Profit Margin6.51%
Oper. Margin11.60%
ROE8.31%
ROA5.42%
Revenue Growth-1.40%
Earnings Growth165.90%
Balance Sheet
Debt/Equity0.08
Current Ratio2.22
Quick Ratio1.43
Book Value/Sh22.62 EUR
Cash/Share4.569 EUR
Dividends
Fwd Div Rate1.350 EUR
Trail. Div Rate1.350 EUR
Div. Yield4.70%
5Y Avg Yield3.32%
Payout Ratio63.83%
Ex-Div DateJun 3, 2026
Pay Date—
Splits
Last Split4:1
Split DateJul 1, 2003
Ownership
Shares Out.17.36M
Float3.50M
Insiders79.00%
Institutions5.33%
Analyst Consensus
Rating—
Target (Mean)25.00 EUR
Target Range25.00 EUR – 25.00 EUR
# Analysts1
Company
Market Cap498.30M EUR
Enterprise Value450.46M EUR
Revenue (TTM)501.11M EUR
Gross Profit365.73M EUR
Net Income (TTM)32.64M EUR
Revenue/Share28.86 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2.4K
Last Price29.00 EUR
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—